NO922635L - Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater - Google Patents

Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater

Info

Publication number
NO922635L
NO922635L NO92922635A NO922635A NO922635L NO 922635 L NO922635 L NO 922635L NO 92922635 A NO92922635 A NO 92922635A NO 922635 A NO922635 A NO 922635A NO 922635 L NO922635 L NO 922635L
Authority
NO
Norway
Prior art keywords
benzimidazoline
oxo
carboxylic acid
new use
acid derivatives
Prior art date
Application number
NO92922635A
Other languages
English (en)
Norwegian (no)
Other versions
NO922635D0 (no
Inventor
Marco Turconi
Franco Borsini
Alessandro Brambilla
Pierino Schiantarelli
Herbert Ladinsky
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of NO922635D0 publication Critical patent/NO922635D0/no
Publication of NO922635L publication Critical patent/NO922635L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO92922635A 1991-07-04 1992-07-03 Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater NO922635L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911845A IT1250629B (it) 1991-07-04 1991-07-04 Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.

Publications (2)

Publication Number Publication Date
NO922635D0 NO922635D0 (no) 1992-07-03
NO922635L true NO922635L (no) 1993-01-05

Family

ID=11360276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922635A NO922635L (no) 1991-07-04 1992-07-03 Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater

Country Status (17)

Country Link
EP (1) EP0523013B1 (fr)
JP (1) JPH05194216A (fr)
KR (1) KR930001906A (fr)
AT (1) ATE115857T1 (fr)
AU (1) AU658197B2 (fr)
CA (1) CA2072911A1 (fr)
DE (1) DE69200948T2 (fr)
DK (1) DK0523013T3 (fr)
GR (1) GR3015413T3 (fr)
HU (2) HUT61462A (fr)
IE (1) IE922174A1 (fr)
IL (1) IL102381A0 (fr)
IT (1) IT1250629B (fr)
MX (1) MX9203900A (fr)
NO (1) NO922635L (fr)
TW (1) TW202386B (fr)
ZA (1) ZA924949B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
WO2001042224A1 (fr) * 1999-12-09 2001-06-14 Mitsubishi Pharma Corporation Derives carboxyamido
CA2601458C (fr) * 2005-03-15 2011-04-26 Pfizer Inc. Derives de benzimidazolone en tant que ligands de recepteur cb2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE3751404T2 (de) * 1986-12-17 1995-12-21 Glaxo Group Ltd Verwendung von heterocyclischen Verbindungen zur Behandlung von Bewusstseinsstörungen.
IT1231413B (it) * 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
US4887422A (en) * 1988-09-06 1989-12-19 Amsted Industries Incorporated Rope with fiber core and method of forming same

Also Published As

Publication number Publication date
EP0523013A3 (fr) 1993-01-27
ITMI911845A1 (it) 1993-01-04
EP0523013B1 (fr) 1994-12-21
DK0523013T3 (da) 1995-05-08
KR930001906A (ko) 1993-02-22
IE922174A1 (en) 1993-01-13
IT1250629B (it) 1995-04-21
IL102381A0 (en) 1993-01-14
TW202386B (fr) 1993-03-21
ATE115857T1 (de) 1995-01-15
HU211855A9 (en) 1995-12-28
HU9202229D0 (en) 1992-10-28
AU658197B2 (en) 1995-04-06
MX9203900A (es) 1993-01-01
DE69200948D1 (de) 1995-02-02
AU1938192A (en) 1993-01-07
GR3015413T3 (en) 1995-06-30
NO922635D0 (no) 1992-07-03
DE69200948T2 (de) 1995-05-18
JPH05194216A (ja) 1993-08-03
HUT61462A (en) 1993-01-28
ZA924949B (en) 1994-01-03
CA2072911A1 (fr) 1993-01-05
ITMI911845A0 (it) 1991-07-04
EP0523013A2 (fr) 1993-01-13

Similar Documents

Publication Publication Date Title
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
NO934500L (no) Ikke-klorfluorcarbonaerosolformuleringer
ES2057604T3 (es) Enantiomero r de n-propargil-1-aminoindano, su preparacion y composiciones farmaceuticas que lo contienen.
NO934499L (no) Ikke-klorfluorcarbonaerosolformuleringer
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK254787D0 (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO304595B1 (no) Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, farmas°ytiske preparater inneholdende dem, og mellomprodukter for fremstilling av dem
DK10488A (da) Benzen-derivater med antiinflammatorisk virkning og fremgangsmaade til fremstilling deraf
MX9202152A (es) Derivados del indol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
NO302368B1 (no) Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
NO922635L (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
NO883986D0 (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
DK47988D0 (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
NO911465D0 (no) Fremgangsmaate for fremstilling av 4-(3-(4-oksotiazoldinyl))-butynylaminer og deres anvendelse som medikamenter.
NO163283C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive n-bicykloheptyl og n-bicykloheptenylimidazoler.
NO883987L (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler